Details for Patent: 8,617,598
✉ Email this page to a colleague
Summary for Patent: 8,617,598
Title: | Pharmaceutical compositions comprising colloidal silicon dioxide |
Abstract: | A pharmaceutical composition comprising a macrolide solid dispersion, a disintegrant and colloidal silicon dioxide, wherein the composition comprises 1 to 5% colloidal silicon dioxide by weight. |
Inventor(s): | Haeberlin; Barbara (Munchenstein, CH), Kramer; Andrea (Reute, DE), Heuerding; Silvia (Basel, CH) |
Assignee: | Novartis AG (Basel, CH) |
Application Number: | 13/489,396 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,617,598 |
Patent Claim Types: see list of patent claims | Composition; Dosage form; Use; Formulation; Process; |
Drugs Protected by US Patent 8,617,598
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,617,598
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 0123400.4 | Sep 28, 2001 |
International Family Members for US Patent 8,617,598
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 036643 | ⤷ Sign Up | |||
Argentina | 097341 | ⤷ Sign Up | |||
Austria | 485813 | ⤷ Sign Up | |||
Brazil | 0212922 | ⤷ Sign Up | |||
Brazil | PI0212922 | ⤷ Sign Up | |||
Canada | 2458455 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |